Keyword: American Diabetes Association
NGM presented data showing that its once-monthly nonalcoholic steatohepatitis drug improved insulin sensitivity in people with diabetes.
The expansion is driven by midphase Type 2 diabetes data suggesting tirzepatide improves markers associated with nonalcoholic steatohepatitis.
Abbott found that the system was able to significantly reduce hemoglobin A1c levels among patients who take multiple insulin injections per day.
Early clinical data from Fractyl showed its outpatient procedure could help eliminate several months’ worth of insulin injections.
Insulet presented new data evaluating the use of its tubeless, closed-loop Omnipod insulin management system in young children with Type 1 diabetes.
The clinical trial data suggest the more integrated approaches to monitoring glucose and delivering insulin offer advantages over today’s setups.
Massachusetts General Hospital scientists have evidence that a TB vaccine prevents the immune system from attacking normal tissues.